Eisai and Biogen have officially launched Leqembi (lecanemab) in South Korea, marking a significant step in Alzheimer’s treatment. The drug, designed for early-stage Alzheimer’s patients, is set to ...
Researchers have linked a specific type of body fat to the abnormal proteins in the brain that are hallmarks of Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback